NCT05685316
ASKEL Cartilage Implant Pilot Clinical Trial
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 37 words Show 5 more changesShow less
- Primary completion date changed from estimate of Sep 30, 2026 to May 5, 2026
- Study completion pushed from Sep 30, 2026 to Dec 2029
- Interventions modified
- Study description expanded, about 16 words
- Study title revised
- Notable Primary and study completion dates: Dec 30, 2024 to Sep 30, 2026
- Trial status: Recruiting to Active, Not Recruiting
- Site details revised at 6 of 6 sites
- Minor Study sites: 5 to 6v4
- Minor Study title expanded, about 3 wordsv3
- Minor Secondary endpoints revised (4)
- Site details revised at 4 of 5 sites
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Number of Serious Adverse Events (SAE)
Timeframe: From pre-operative baseline up to 24-month follow-up visit
Secondary (4)
Defect filling
Change in pain score
Functional outcome
Change in Quality of life
Arms and interventions
ASKEL Cartilage ImplantExperimental
The potential subjects will be screened against inclusion and exclusion criteria. If deemed eligible, they will be consented and enrolled. The enrolled subjects will receive ASKEL device during normal clinical practice for cartilage repair surgery with bone marrow stimulation.
Devices: ASKEL Cartilage Implant
Sites
6 sites in 3 countries
Finland 4, Estonia 1, Sweden 1